Biotech, Pharma Stocks Surge as IPAB Not Triggered
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall St muted ahead of Nvidia results, hot inflation fuels rate-hike bets
- Oil falls as investors focus on Hormuz talks
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Boston Scientific discloses cybersecurity incident causing global disruption
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
Pharma Rumor Mill Working Overtime
June 22, 2016 3:53 PM EDTIn addition to the positive implications from the IPAB not being triggered, there is a lot of under-the-radar chatter going around today about a possible mega-deal in the biotech/pharma space.
Two specific deals were mentioned in the rumor mill today:
Pfizer (NYSE:... More